Info
Schedule 13D
Ownership

Third Rock Ventures IV, L.P. - Significant Ownership

Signature - Title: /s/ Kevin Gillis - Kevin Gillis, Chief Operating Officer of TRV GP IV, LLC, gen. partner of Third Rock Ventures GP IV, L.P., gen. partner of Third Rock Ventures IV, L.P.
Location: Boston, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Third Rock Ventures IV, L.P..

Significant Ownership of Third Rock Ventures IV, L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
MAZE	Maze Therapeutics, Inc.	Common Stock, $0.001 par value per share	13.9%	$53.4M		6.07M		Third Rock Ventures IV, L.P.	Jan 31, 2025

Showing 1 to 1 of 1 entries

Schedules 13D/G Reported by Third Rock Ventures IV, L.P.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.